Skip to main content
editorial
. 2020 Apr 30;6(2):52–60. doi: 10.1016/S2055-6640(20)30017-0

Figure 2.

Figure 2.

(a) Event proportions occurring across reported safety endpoints in all nine included studies (both placebo controlled and active controlled). (b) Event proportions occurring across reported safety endpoints, stratified into results from studies using a placebo controlled and studies using active antimicrobial control.

AE: adverse events; P = n.s: P-value non-significant; SAE: serious adverse events; Gr: grade; GI: gastrointestinal; PYFU: person-years-of-follow-up